ArticleFrontiers in oncology2026
A novel combined model integrating collagen properties, radiomics and clinical data to predict gastric cancer prognosis.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Gastric cancer (GC) is one of the most common malignant tumors in the world, and there is still no good method to predict the prognosis of GC patients. Collagens are the major component of the extracellular matrix (ECM), and abnormalities in collagen are closely associated with the development of GC. Methods: This study investigated collagen signatures in GC using bioinformatics analysis and picrosirius red staining. A total of 196 GC patients were included, with 138 assigned to the training group and 58 to the validation group. Multivariate analysis was performed to evaluate prognostic factors, and a predictive model was constructed by integrating collagen properties, radiomics, and clinical data. Results: The study revealed that collagen signatures were associated with GC initiation and progression. Multivariate analysis confirmed that the picrosirius red risk score (HR = 1.1, 95% CI: 1.02-1.18, p = 0.013) and Radscore (HR = 2.34, 95% CI: 1.3-4.21, p = 0.005) were independent prognostic factors for overall survival. The combined model demonstrated high accuracy, with a C-index of 0.9 in the training group and 0.84 in the validation group, along with good goodness of fit and net benefit. Discussion: These findings suggest that a prognostic model integrating multiple types of data, including collagen characteristics, radiomics, and clinical factors, can better predict the overall survival of GC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.